Access to therapy is part of the protection of the constitutional order: Peter Bely spoke at the SPIEF session on intellectual property
18.06.2022
Industry development
18.06.2022
There will be more innovative medicines developed in our country. This is exactly what the agreements signed by the Promomed Group of companies during the St. Petersburg International Economic Forum are aimed at. Thus, the company's production site is the state—of-the-art Biochemist complex, which collaborates with the Skolkovo Foundation. First of all, this is research in the field of biotechnology, obtaining both raw materials for medicines and finished products.
In addition, the agreements involve the company's cooperation with leading specialized universities in the country. These are the Mendeleev Russian Technical Technical University, Ogarev Mordovian University, and Moscow State Medical and Dental University. Moreover, this is not just about training personnel, but highly specialized specialists of the highest level. And also about the popularization of professions for the pharmaceutical industry. Promomed implements all these projects in order to facilitate the implementation of the state program for the development of the domestic medical industry.
"Today's event is an opportunity for us to significantly expand the number of applicants we can train at the country's leading universities and then obtain highly qualified personnel. Moreover, these are people who have been working since school in the conditions in which they will continue to work professionally. It is very important that this education is not for obtaining a diploma, but for work in which the knowledge that is directly needed for direct professional activity is obtained," said Peter Bely, Chairman of the Board of Directors of Promomed Group.
Source: tvzvezda.ru
Sources
Get the most interesting news and publications first!
Sent successfully!
Press office
To request a press release or interview, please contact our press office
